GBM, for a new guy to the thread, I wonder why you're even here. It would seem that people who are new would be interested in buying. I don't get that sense from you at all. Bottom line, this is a growth stock, and offers potential rates of return which will dramatically surpass blue chip investments. The downside is that the risk of loss is usually higher too. I've been watching this company for two years, and am convinced that whatever problems they had in the past in terms of getting the product to market are resolved. If they can achieve even $10,000,000 in sales, they should earn about $1 per share (Sale price $70, cost to produce $15, float 8,000,000). Based on a conservative p/e ratio of 20 (for bio tech stocks in a period of growth, 80 is not unreasonable), the share value should be $20, a 300% increase over current prices. And that is probably achievable with the year. Is it any wonder the shorters are panicking?
GM |
